OOIR: Observatory of International Research

Papers

(The H4-Index of Cell Host & Microbe is 79. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies	960
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition	904
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization	650
Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization	458
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite	453
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity	447
The Gut Virome Database Reveals Age-Dependent Patterns of Virome Diversity in the Human Gut	394
Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains	316
Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis	312
The variant gambit: COVID-19’s next move	306
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines	284
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization	276
SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19	252
Developmental trajectory of the healthy human gut microbiota during the first 5 years of life	248
Root-Secreted Coumarins and the Microbiota Interact to Improve Iron Nutrition in Arabidopsis	241
Integrative Imaging Reveals SARS-CoV-2-Induced Reshaping of Subcellular Morphologies	236
A Comprehensive Subcellular Atlas of the Toxoplasma Proteome via hyperLOPIT Provides Spatial Context for Protein Functions	233
Living in the endosymbiotic world of Wolbachia: A centennial review	212
Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19	207
Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant	195
An expanded arsenal of immune systems that protect bacteria from phages	193
Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2	181
SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape	174
Role of dietary fiber in the recovery of the human gut microbiome and its metabolome	172
Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles	166

Enteroendocrine cells sense bacterial tryptophan catabolites to activate enteric and vagal neuronal pathways	165
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses	164
Phages and their satellites encode hotspots of antiviral systems	164
SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera	164
Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19	156
Nucleocapsid mutations R203K/G204R increase the infectivity, fitness, and virulence of SARS-CoV-2	151
Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission	147
Commensal microbiota regulates skin barrier function and repair via signaling through the aryl hydrocarbon receptor	139
A bacterial bile acid metabolite modulates Treg activity through the nuclear hormone receptor NR4A1	137
The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants	131
Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2, and BA.3 sub-lineages	126
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans	125
Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors	123
Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75	123
Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant	123
Human gut bacterial metabolism drives Th17 activation and colitis	118
Commensal Staphylococcus epidermidis contributes to skin barrier homeostasis by generating protective ceramides	118
The immune landscape in tuberculosis reveals populations linked to disease and latency	117
Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease	114
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models	112
Shigella ubiquitin ligase IpaH7.8 targets gasdermin D for degradation to prevent pyroptosis and enable infection	110
Global COVID-19 vaccine inequity: The scope, the impact, and the challenges	108
Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2	108
Antibody and B cell responses to SARS-CoV-2 infection and vaccination	107
Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner	106
Organoids and organs-on-chips: Insights into human gut-microbe interactions	104
Human-Gut-DNA Virome Variations across Geography, Ethnicity, and Urbanization	104
Distinct Polysaccharide Utilization Determines Interspecies Competition between Intestinal Prevotella spp.	103
Bacteria induce skin regeneration via IL-1β signaling	101
Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response	100
Rethinking healthy eating in light of the gut microbiome	97
Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses	94
Plant immune system activation is necessary for efficient root colonization by auxin-secreting beneficial bacteria	92
Aberrant gut-microbiota-immune-brain axis development in premature neonates with brain damage	92
Dynamics of the normal gut microbiota: A longitudinal one-year population study in Sweden	92
Gut microbiome dysbiosis contributes to abdominal aortic aneurysm by promoting neutrophil extracellular trap formation	92
Microbiota regulate innate immune signaling and protective immunity against cancer	91
Supplementation with a probiotic mixture accelerates gut microbiome maturation and reduces intestinal inflammation in extremely preterm infants	89
Western diet induces Paneth cell defects through microbiome alterations and farnesoid X receptor and type I interferon activation	88
A complex immune response to flagellin epitope variation in commensal communities	88
Anatomy promotes neutral coexistence of strains in the human skin microbiome	86
Gut microbes impact stroke severity via the trimethylamine N-oxide pathway	86
Helicobacter pylori CagA elicits BRCAness to induce genome instability that may underlie bacterial gastric carcinogenesis	84
Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies	84
SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals	84
Exploration of Bacterial Bottlenecks and Streptococcus pneumoniae Pathogenesis by CRISPRi-Seq	83
Tissue-resident Lachnospiraceae family bacteria protect against colorectal carcinogenesis by promoting tumor immune surveillance	82
A microbial metabolite remodels the gut-liver axis following bariatric surgery	82
Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumors	81
Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections	81

Gut microbiome lipid metabolism and its impact on host physiology	80
Vaccinia virus E3 prevents sensing of Z-RNA to block ZBP1-dependent necroptosis	79
The great escape? SARS-CoV-2 variants evading neutralizing responses	79
Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2	79
Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75	79
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses	79